Our host, Lori La Bey talks with Todd Langevin, the CEO of Functional Neuromodulation, about their clinical trial using deep brain stimulation referred to as DBS. We will find out who the ideal candidates are for their trial, where it's available and how it works. We will also talk about safety issues since Covid hit and how they are proceeding with their ADvance II trial.
Contact Functional Neuromodulation
Email: info@fxneuromod.com
Phone: 1-866-296-4040 Press Option #1
Websites: [ Ссылка ] www.mildalzheimersstudy.com
Contact Lori La Bey with questions or branding needs through www.AlzheimersSpeaks.com
Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sounds news, not just sound bites since 2011.
